Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» BridgeBio Pharma
BridgeBio Pharma
BridgeBio makes $250M in securities sale while planning acoramidis commercial launch
BridgeBio makes $250M in securities sale while planning acoramidis commercial launch
Fierce Biotech
BridgeBio Pharma
acoramidis
Flag link:
BridgeBio bounces back? Phase 2 readout provides hope for approval of drug to rebalance calcium levels
BridgeBio bounces back? Phase 2 readout provides hope for approval of drug to rebalance calcium levels
Fierce Biotech
BridgeBio Pharma
clinical trials
encaleret
autosomal dominant hypocalcemia
Flag link:
After layoffs, BridgeBio turns to dealmaking for up to 6 drugs
After layoffs, BridgeBio turns to dealmaking for up to 6 drugs
Fierce Biotech
BridgeBio Pharma
layoffs
restructuring
out-licensing
Flag link:
BridgeBio plots path to market for muscular dystrophy drug after posting phase 2 data
BridgeBio plots path to market for muscular dystrophy drug after posting phase 2 data
Fierce Biotech
BridgeBio Pharma
limb-girdle muscular dystrophy
clinical trials
BBP-418
Flag link:
Biopharma developments over the Christmas period
Biopharma developments over the Christmas period
EP Vantage
Alnylam Pharmaceuticals
Bio-Thera Solutions
BioArctic
Biogen
BridgeBio Pharma
Daiichi Sankyo
Eisai
JNJ
Madrigal Pharmaceuticals
Merck
Sutro BioPharma
Tasly Pharmaceutical Group
Flag link:
